From viewing the heatmap in Figure 2, it is evident that, when used alone, some compounds elicit DHT-like activity in terms of AR protein stabilization (e.g., nilutamide, OHF) and translocation, especially in prostate cancer cells (LNCaP and C4-2) as compared to breast cancer lines. This evidence concerns the gene AR and prostate carcinoma.